Further studies on the tumor-inhibitory and tumor-inducing properties of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine hydrochloride).
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D001565:Benzoates / Q000627:therapeutic use*; D006224:Cricetinae; D006990:Hypnosis; D007274:Injections, Intraperitoneal; D007939:Leukemia L1210 / Q000188:drug therapy; D008175:Lung Neoplasms / Q000139:chemically induced; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy; D012878:Skin Neoplasms / Q000139:chemically induced
D001565:Benzoates